Nuvectis Pharma, Inc. (NVCT) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $31.63M | +70.7% |
| 2024 | $18.53M | -3.1% |
| 2023 | $19.13M | -4.3% |
| 2022 | $19.99M | +248.2% |
| 2021 | $5.74M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $31.63M | +70.7% |
| 2024 | $18.53M | -3.1% |
| 2023 | $19.13M | -4.3% |
| 2022 | $19.99M | +248.2% |
| 2021 | $5.74M | — |